logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
返回期刊详情
O

Oncology Research and Treatment

IF1.6
论文数29
被引数1343
期刊论文 29
发表时间
delete
RETRACTION: TACE Combined with Hepatic Arterial Infusion of Nivolumab for Inhibiting Tumor Angiogenesis in Hepatocellular Carcinoma撤稿：TACE联合肝动脉灌注纳武利尤单抗抑制肝癌肿瘤血管生成
deleteOncology Research and Treatment
IF1.6
delete2026-04-01
delete0
PREAI
deleteZhang, Sujing; Zheng, Zheng; Zhang, Changwang; Liu, Xueqian; Shi, Xinlei; Ma, Wenhua
delete分享
delete收藏
Lung Cancer: SCLC and NSCLC. Reliable Immunotherapy in Real-World Clinical Practice肺癌：小细胞肺癌和非小细胞肺癌。真实世界临床实践中的可靠免疫治疗
deleteOncology Research and Treatment
IF1.6
delete2026-03-01
delete0
PREAI
deleteSchmale, Ine
delete分享
delete收藏
Real-world evidence for daratumumab-CyBorD in AL amyloidosis达雷木单抗-CyBorD在AL淀粉样变性中的真实世界证据
deleteOncology Research and Treatment
IF1.6
delete2026-03-01
delete0
PREAI
deleteAndreas, Sabine
delete分享
delete收藏
(Un-)Known Chances: Emerging Hope for Cancer of Unknown Primary - Highlights from ESMO 2025 and the First International Cancer of Unknown Primary Meeting(未知)的机遇：未知原发灶癌症的涌现希望——ESMO 2025和首届国际未知原发灶癌症会议要点
deleteOncology Research and Treatment
IF1.6
delete2026-03-01
delete0
PREAI
deleteHaas, Maximilian; Hempel, Louisa; Kramer, Alwin; Hubner, Gerdt
delete分享
delete收藏
Balanced Treatment Goals in Multiple Myeloma: Melflufen between Efficacy, Safety, and Quality of Life多发性骨髓瘤的平衡治疗目标：美氟新在疗效、安全性与生活质量之间
deleteOncology Research and Treatment
IF1.6
delete2026-02-01
delete0
PREAI
deleteBruer, Christian
delete分享
delete收藏
Quality of Life and Patient-Reported Outcomes: Highlights from the European Society for Medical Oncology Annual Meeting Congress 2025生活质量与患者报告结局：2025年欧洲肿瘤内科学会年会亮点
deleteOncology Research and Treatment
IF1.6
delete2026-02-01
delete0
PREAI
deleteHamm, Anna Franziska; Michaeli, Thomas
delete分享
delete收藏
Apatinib Mesylate in the Treatment of Advanced Triple-Negative Breast Cancer甲磺酸阿帕替尼在治疗晚期三阴性乳腺癌中的应用
deleteOncology Research and Treatment
IF1.6
delete2026-02-01
delete0
PREAI
deleteHuang, Xijia; Chen, Chao; Zeng, Hao; Wang, Lili; Chen, Mulan; Liu, Jian; Wu, Fan; Huang, Weiwei
delete分享
delete收藏
The PharmaNews医药新闻
deleteOncology Research and Treatment
IF1.6
delete2026-02-01
delete0
PREAI
deleteArnheim, Katharina
delete分享
delete收藏
KRAS Inhibition in Non-Small Cell Lung Cancer with Central Nervous System Involvement: Current Evidence and Future DirectionsKRAS抑制剂在伴有中枢神经系统受累的非小细胞肺癌中的研究现状与未来方向
deleteOncology Research and Treatment
IF1.6
delete2026-02-01
delete0
PREAI
deletePereira, Rafael Alvim; Oliveira, Christian; Tumelero, Milena; Fernandes, Humberto; Lenz, Gabriel
delete分享
delete收藏
37th German Cancer Congress Together Targeted Future-Ready ABSTRACTS Abstracts第37届德国癌症大会：共同靶向未来-摘要
deleteOncology Research and Treatment
IF1.6
delete2026-02-01
delete0
PREAI
delete[Anonymous]
delete分享
delete收藏
Vulnerability to Infections and Secondary Immunodeficiencies in Patients with Non-Hodgkin's Lymphomas Starting Anti-CD20 Antibody-Containing Therapies非霍奇金淋巴瘤患者接受含抗CD20抗体治疗时的感染易感性和继发性免疫缺陷
deleteOncology Research and Treatment
IF1.6
delete2026-02-01
delete0
PREAI
deleteWeide, Rudolf; Mohm, Johannes; Gartner, Michael; Fuxius, Stefan; Vehling-Kaiser, Ursula; Forstbauer, Helmut; Lipke, Jorg; Rothe, Achim; Verpoort, Karl; Feiten, Stefan
delete分享
delete收藏
Proliferation-Guided Risk Stratification in HER2-Low versus HER2-Positive Hormone Receptor-Positive Breast Cancer: A Multicenter Retrospective AnalysisHER2低表达与HER2阳性激素受体阳性乳腺癌的增殖指导风险分层：一项多中心回顾性分析
deleteOncology Research and Treatment
IF1.6
delete2026-01-01
delete0
PREAI
deleteKitapli, Sait; Tanriverdi, Ozgur; Bayrakci, Ismail; Guclu, Taliha; Demir, Bilgin; Colak, Gokhan; Alkan, Ali; Turan, Merve; Oktay, Esin; Gokoz Dogu, Gamze; Uzunoglu, Sernaz; Barutca, Sabri
delete分享
delete收藏
Clinical Prognostic Significance of LRG1 in Metastatic Breast CancerLRG1在转移性乳腺癌中的临床预后意义
deleteOncology Research and Treatment
IF1.6
delete2026-01-01
delete0
PREAI
deleteMuendlein, Axel; Brandtner, Eva Maria; Heinzle, Christine; Geiger, Kathrin; Leiherer, Andreas; Benda-Beck, Magdalena; Reimann, Patrick; Dechow, Tobias; Decker, Thomas
delete分享
delete收藏
Cabozantinib in RAI-refractory DTC - a treatment option with explicit evidence for second-line use卡博替尼在RAI难治性DTC中的研究——一种具有明确证据支持二线治疗的选择
deleteONCOLOGY RESEARCH AND TREATMENT
IF1.6
delete2025-12-01
delete0
PREAI
delete[Anonymous]
delete分享
delete收藏
The PharmaNews医药新闻
deleteONCOLOGY RESEARCH AND TREATMENT
IF1.6
delete2025-12-01
delete0
PREAI
deleteMoser, Susanne
delete分享
delete收藏
ESMO/DGHO Congress 2025 Current developments in the treatment of lung cancerESMO/DGHO 大会 2025 肺癌治疗领域的最新进展
deleteONCOLOGY RESEARCH AND TREATMENT
IF1.6
delete2025-12-01
delete0
PREAI
deleteKrampe-Scheidler, Anne
delete分享
delete收藏
Frontline Pembrolizumab or Methotrexate in Elderly, Frail, or Cisplatin-Ineligible Patients with Relapsed or Metastatic Squamous Cell Carcinoma of the Head and Neck: Results of the Randomized Phase 2 Study ELDORANDO (AIO-KHT-0115)一线帕博利珠单抗或甲氨蝶呤在老年、虚弱或顺铂不耐受的复发或转移性头颈部鳞状细胞癌患者中的疗效：随机II期研究ELDORANDO（AIO-KHT-0115）的结果
deleteOncology Research and Treatment
IF1.6
delete2025-12-01
delete0
PREAI
deleteKlinghammer, Konrad; Graeven, Ullrich; Ivanyi, Philipp; Dietz, Andreas; Hahn, Dennis; Hackenberg, Stephan; Kasper, Stefan; Haderlein, Marlen; Pink, Daniel; Tinhofer, Ingeborg; Schaaf, Marina; Sookthai, Disorn; Gruenwald, Viktor
delete分享
delete收藏
Cabozantinib in HCC - An established 2L therapy standard in clinical practice
deleteONCOLOGY RESEARCH AND TREATMENT
IF1.6
delete2025-11-01
delete0
PREAI
delete[Anonymous]
delete分享
delete收藏
For older patients with MCL, acalabrutinib plus BR is the option of choice for me
deleteONCOLOGY RESEARCH AND TREATMENT
IF1.6
delete2025-11-01
delete0
PREAI
deleteWelslau, Manfred
delete分享
delete收藏
ER+/HER2-metastatic breast cancer. Capivasertib plus fulvestrant in advanced metastatic breast cancer with PIK3CA/AKT1/PTEN alteration(s)
deleteONCOLOGY RESEARCH AND TREATMENT
IF1.6
delete2025-11-01
delete0
PREAI
deleteDuenisch, Meike
delete分享
delete收藏